AZD2115 Multiple Ascending Dose Study

NCT01445782 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: AZD2115
DRUG: Placebo

Sponsor

AstraZeneca